Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-1.48%	20.99	$
RBGPF	5.18%	72.24	$
BCC	-2.56%	75.84	$
NGG	-0.01%	79.15	$
GSK	0.81%	50.66	$
CMSD	-1.83%	20.78	$
BCE	-0.77%	23.41	$
RELX	-2.04%	35.7	$
JRI	-0.08%	12.17	$
RIO	-0.63%	101.86	$
BTI	0.63%	55.92	$
RYCEF	-2.5%	19.59	$
AZN	0.21%	162.47	$
BP	3.6%	44.47	$
VOD	0.06%	16.05	$

Featured

Funerals in Nepal for missing, a week after deadly floods

Nepali families were holding symbolic funeral ceremonies to "liberate the souls" of loved ones missing since deadly flash floods swept away their villages and homes in the Himalayan region a week ago.

US aircraft carrier arrives in Thailand after months at sea

A US aircraft carrier at the centre of controversy over conditions on board arrived in Thailand on Wednesday for its first port call in nine months.

Last news

MEMRI Congratulates Board Of Advisors Member Brig. Gen. Tom Consentino On New Role

WASHINGTON, DC / ACCESS Newswire / May 14, 2025 / The Middle East Media Research Institute (MEMRI) congratulates our Board of Advisors member Brig. Gen. Tom Cosentino on his new role as CEO of Governance Risk Global Holdings (GRG).

Desert Oasis Healthcare Leads the Way in Dementia Detection with Cutting-Edge Digital Screening Tool

Neurotrack's screening platform helped to increase the rate of dementia detection by 29% in four months

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

- Dermata announced positive topline results from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial, achieving all co-primary endpoints -- Dermata entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics to study DMT410 with DAXXIFY® for the treatment of axillary hyperhidrosis -- Raised $8.8 million in gross proceeds from private placement and warrant inducement financings during the first quarter of 2025 -

Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R

Blackrock Neurotech to begin immediate sales of Cognixion's Axon-R wearable BCI + augmented reality platform, paving the way for integration of implantable BCI with immersive computing applications

Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates

Click here to registerCompany plans to file its Earnings Report on May 15, 2025 on Form 10-Q for the quarter ended March 31, 2025

Interactive Strength Inc. (Nasdaq:TRNR) To Release First Quarter 2025 Results on Monday, May 19th

Company also expects to provide Q1 performance update pro forma for the pending acquisitions of Sportstech and Wattbike

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

412% revenue growth reflects AI Nose sales in elderly careExpanding AI-driven scent tech beyond healthcare into robotics and industrial applications

Reservoir Media to Release Fourth Quarter and Fiscal Year 2025 Results on May 28, 2025

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Reservoir Media, Inc. (NASDAQ:RSVR) ("Reservoir" or the "Company"), an award-winning independent music company, today announced that it will release financial results for the fourth fiscal quarter and fiscal year 2025 ended March 31, 2025, before market open on Wednesday, May 28, 2025.

Specificity Builds Dominant CTV Campaign Capabilities, Reinforces Position as Industry's Leading Hybrid Marketing Agency

TAMPA, FLORIDA / ACCESS Newswire / May 14, 2025 / Specificity, Inc. (OTC PINK:SPTY), the marketing industry's only true hybrid model agency, today announced the expansion of its cutting-edge Connected TV (CTV) advertising capabilities, delivering unmatched performance, precision, and value for clients looking to reach real, in-market audiences.

Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics

Fenjiu Liquor Elegance, Shared Worldwide: Asia-Pacific Cuisine Sino-Singapore Forum Successfully Concludes in Auckland

Fenjiu Shines at Asia-Pacific Culinary Forum: China-New Zealand Fusion Captivates Auckland

Coca-Cola Europacific Partners plc Announces Capital Markets Event

UXBRIDGE, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / CCEP today hosts a Capital Markets Event in Manila for analysts and investors.

Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol

Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML

UN agency finds Russia responsible for 2014 downing of airliner over Ukraine

The United Nations aviation agency has blamed Russia for the downing of a Malaysian jetliner over Ukraine in 2014, leading to the deaths of 298 people, a ruling dismissed by Moscow on Tuesday as "biased."

'I thought I was going to die,' Kardashian tells Paris robbery trial

Reality TV star Kim Kardashian told a Paris court on Tuesday she feared she would be killed by the masked men who robbed her at gunpoint of some $10 million of jewellery in her hotel room in 2016.

Sean 'Diddy' Combs' ex Cassie expected to testify

Sean "Diddy" Combs's former partner Casandra Ventura is expected to testify at his trial Tuesday with a now infamous clip of the fallen music mogul allegedly beating the singer expected to dominate questioning.

French court convicts Depardieu of sexual assault

A Paris court on Tuesday handed French cinema icon Gerard Depardieu an 18-month suspended sentence after convicting him of sexually assaulting two women on a film set in 2021.

Medical charity condemns Israel's use of hunger as 'weapon of war' in Gaza

A months-long Israeli blockade is worsening acute malnutrition in the Gaza Strip, medical charity Medecins du Monde warned on Tuesday, accusing Israel of using hunger as "a weapon of war".

Gerard Depardieu: a tarnished French film icon

Gerard Depardieu was a titan of French cinema for more than 50 years but a sexual assault conviction, a string of other allegations and several instances of lewd behaviour now cast a long, dark shadow over what was once a glittering career.

Tariffs set to level up game console prices

The US tariffs barrage and the bounding cost of producing games have prompted manufacturers like Sony and Microsoft to announce price hikes on consoles, in an industry shift experts say is set to last.

Jaded young Chinese reset lives with rural 'retirement'

Wang Dong hasn't worked for months and doesn't plan to, whiling away his days at a lakeside town as one of a growing number of young Chinese "retiring" in the countryside.

Verdict due in Depardieu sexual assault case

A Paris court is to deliver a verdict Tuesday in the sexual assault trial of French cinema icon Gerard Depardieu, in a case that has further tarnished the reputation of one of France's greatest stars.

'Unlimited power': Testimony against Sean Combs tells of lurid violence

The courtroom fell eerily silent as the footage of Sean "Diddy" Combs beating, kicking and dragging his then-girlfriend began -- a video already seen worldwide but which took on new gravity played before the jurors who will determine his future.

Angel Media Unveils Iconic New Hand-Painted Billboard in NYC’s Meatpacking District

This premium wallscape is more than just advertising - it's cultural placement. The Meatpacking District is a global destination known for its fashion-forward crowd, luxury retail, buzzing nightlife, and creative energy. This location puts brands front and center in a high-foot-traffic corridor surrounded by art galleries, tech headquarters, and trendsetting locals and tourists alike.

NHI Responds to ISS Recommendation

Urges Shareholders to Vote FOR NHI's Director Nominees on the WHITE Proxy CardStrongly Disagrees with ISS' Recommendation; Believes that it Would Put at Risk Company's Superior Shareholder Returns

Ensysce Biosciences Reports First Quarter 2025 Financial Results

Receives U.S. Patent for Groundbreaking Treatment for Opioid Use DisorderClinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection

Tenon Medical Reports First Quarter 2025 Financial Results

~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and International Patents ~~ Received Gross Proceeds of ~$7.0 Million from Equity Financing Transactions ~~ National Commercial Launch of Catamaran SE in Mid-2025 ~

Dolphin Reports Q1 2025 Results; Core Entertainment Publicity and Marketing Segment (EPM) Revenue Up 2% YoY to $12.1 Million, Strategic Investments and New Division Launch to Drive Long-Term Growth

Highlights Talent Expansion, Women's Sports Investment, Affiliate Marketing Launches, and Continued Industry RecognitionNamed 2025 Agency of the Year by Observer's PR Power List

Theranexus and Beyond Batten Disease Foundation Announce Strong Positive Real-World Data Supporting Batten-1 Efficacy for the Treatment of Batten Disease

LYON, FRANCE and AUSTIN, TX / ACCESS Newswire / May 13, 2025 / Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, and the Beyond Batten Disease Foundation (BBDF) today announced new real-world data strongly supporting the efficacy of Batten-1 (miglustat) as a treatment for CLN3 disease, also known as juvenile Batten disease.

CERTIFY Health Secures Growth Equity Investment from ABS Capital Partners to Accelerate Patient Engagement Innovation

New Investment Accelerates CERTIFY Health's Mission to Revolutionize Patient Engagement and Streamline Healthcare Operations

CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common Stock) (or common stock equivalents in lieu thereof), at a purchase price of $1.265 per share of Common Stock. The Company further agreed to issue to the investors Series F Common Stock purchase warrants to purchase up to 3,952,570 shares of Common Stock (the "Series F Warrants"). The Series F Warrants will have an exercise price of $1.14 per share, will be exercisable immediately following the date of their issuance and will expire in five years.

Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.

Arizona Tribune - Boulevard (English)